ArticleERJ open research2026
Inspiratory muscle training improves exercise performance and breathing pattern during 6-min walking test in systemic sclerosis-associated interstitial lung disease.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic sclerosis-associated interstitial lung disease (SSc-ILD) significantly impacts exercise capacity and contributes to morbidity and mortality in affected individuals. Inspiratory muscle training (IMT) has demonstrated benefits in improving inspiratory muscle strength and respiratory efficiency in various cardiopulmonary conditions, including interstitial lung disease. This case-control study hypothesises that IMT can enhance inspiratory muscle strength and exercise capacity in patients with SSc-ILD, likely through improved ventilatory patterns during exercise. In this randomised, placebo-controlled trial, 24 patients with SSc-ILD (4 males, 20 females) were randomly assigned to the IMT (n=12) or sham (n=12) groups. The IMT group performed training at 60% of maximal inspiratory pressure (MIP) for 5 weeks, while the sham group received a placebo intervention at 5% MIP. Baseline and post-intervention assessments included pulmonary function tests, 6-min walk test (6MWT) with combined wearable metabolic system to measure minute ventilation (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.